Please assess the completion status of the following clinical trial:

Trial Title: Effects of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diabetes mellitus, type 1~* Levels of HbA1C (glycated hemoglobin) \<7.4% (NGSP standard)~* Levels of HbA1C \>8.4% (NGSP standard)~Exclusion Criteria:~* Prior aspirin treatment~* Treatment with anticoagulant drugs~* Ongoing treatment with NSAIDs or other antiplatelet drugs~* A history of macrovascular disease

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Aspirin 75mg (Type: ACTIVE_COMPARATOR): None
- Aspirin 320mg (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).